GB1434919A - 3alpha-hydroxy androstanes - Google Patents

3alpha-hydroxy androstanes

Info

Publication number
GB1434919A
GB1434919A GB2811872A GB2811872A GB1434919A GB 1434919 A GB1434919 A GB 1434919A GB 2811872 A GB2811872 A GB 2811872A GB 2811872 A GB2811872 A GB 2811872A GB 1434919 A GB1434919 A GB 1434919A
Authority
GB
United Kingdom
Prior art keywords
hydroxy
cyano
steroids
androstan
positions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2811872A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB2811872A priority Critical patent/GB1434919A/en
Priority to AU56937/73A priority patent/AU477852B2/en
Priority to CA174,050A priority patent/CA1040619A/en
Priority to DE2330342A priority patent/DE2330342A1/de
Priority to ZA734037A priority patent/ZA734037B/xx
Priority to DK328673AA priority patent/DK136157B/da
Priority to BE132254A priority patent/BE800899R/xx
Priority to NL7308267A priority patent/NL7308267A/xx
Priority to FR7321743A priority patent/FR2189034B2/fr
Priority to LU67790A priority patent/LU67790A1/xx
Priority to US05/481,227 priority patent/US3943124A/en
Publication of GB1434919A publication Critical patent/GB1434919A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
GB2811872A 1970-12-17 1972-06-15 3alpha-hydroxy androstanes Expired GB1434919A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes
AU56937/73A AU477852B2 (en) 1972-06-15 1973-06-14 3-hydroxy androstanes
CA174,050A CA1040619A (en) 1972-06-15 1973-06-14 Steroids of the androstane series, having anaesthetic activity
DE2330342A DE2330342A1 (de) 1972-06-15 1973-06-14 Steroidverbindungen
ZA734037A ZA734037B (en) 1972-06-15 1973-06-14 Compounds of the androstane series having anaesthetic activity
DK328673AA DK136157B (da) 1972-06-15 1973-06-14 Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-17beta-karboxylsyrederivater af androstanrækken eller salte deraf.
BE132254A BE800899R (fr) 1972-06-15 1973-06-14 Composes de la serie de l'androstane a activite anesthesique et leur preparation
NL7308267A NL7308267A (enExample) 1972-06-15 1973-06-14
FR7321743A FR2189034B2 (enExample) 1972-06-15 1973-06-14
LU67790A LU67790A1 (enExample) 1972-06-15 1973-06-14
US05/481,227 US3943124A (en) 1970-12-17 1974-06-20 Chemical compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
GB1434919A true GB1434919A (en) 1976-05-12

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2811872A Expired GB1434919A (en) 1970-12-17 1972-06-15 3alpha-hydroxy androstanes

Country Status (9)

Country Link
BE (1) BE800899R (enExample)
CA (1) CA1040619A (enExample)
DE (1) DE2330342A1 (enExample)
DK (1) DK136157B (enExample)
FR (1) FR2189034B2 (enExample)
GB (1) GB1434919A (enExample)
LU (1) LU67790A1 (enExample)
NL (1) NL7308267A (enExample)
ZA (1) ZA734037B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20190232T1 (hr) 2013-04-17 2019-03-22 Sage Therapeutics, Inc. 19-nor c3,3-disupstituirani c21-n-pirazolil steroidi i postupci za njihovu upotrebu
HRP20200995T1 (hr) 2013-04-17 2020-11-27 Sage Therapeutics, Inc. 19-nor neuroaktivni steroidi za metode liječenja
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
SMT202100229T1 (it) 2013-07-19 2021-05-07 Sage Therapeutics Inc Steroidi neuroattivi, composizioni e loro usi
SMT202100048T1 (it) 2013-08-23 2021-03-15 Sage Therapeutics Inc Steroidi neuroattivi, composizioni e loro usi
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JP6742308B2 (ja) 2014-10-16 2020-08-19 セージ セラピューティクス, インコーポレイテッド Cns障害を処置するための組成物および方法
AU2015331749A1 (en) 2014-10-16 2017-05-04 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
ES2793237T3 (es) 2014-11-27 2020-11-13 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
SI3250210T1 (sl) 2015-01-26 2021-07-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN109689673B (zh) 2016-07-11 2023-03-14 萨奇治疗股份有限公司 C17、c20和c21取代的神经活性类固醇及其使用方法
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
CN114206900A (zh) 2019-05-31 2022-03-18 萨奇治疗股份有限公司 神经活性类固醇及其组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
DE2162555A1 (de) * 1970-12-17 1972-06-22 Glaxo Laboratories Ltd., Greenford, Middlesex (Grossbritannien) Anästhetisch wirkende Steroidverbindungen
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof

Also Published As

Publication number Publication date
DK136157B (da) 1977-08-22
DK136157C (enExample) 1978-01-23
LU67790A1 (enExample) 1973-08-16
NL7308267A (enExample) 1973-12-18
FR2189034A2 (enExample) 1974-01-25
AU5693773A (en) 1974-12-19
CA1040619A (en) 1978-10-17
ZA734037B (en) 1974-05-29
BE800899R (fr) 1973-12-14
DE2330342A1 (de) 1974-01-17
FR2189034B2 (enExample) 1977-01-21

Similar Documents

Publication Publication Date Title
GB1434919A (en) 3alpha-hydroxy androstanes
GB1515284A (en) Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
NL179059C (nl) Werkwijze ter bereiding van een geneesmiddel met ontstekingsremmende werking, gevormd geneesmiddel en werkwijze ter bereiding van geneeskrachtige verbindingen, geschikt voor gebruik bij deze werkwijze.
GB1440064A (en) Delta8-9- steroids of the pregnane series
GB1363460A (en) Rofluoropregnenes
GB1416475A (en) 21-orthoesters of cortical steroids and methods of preparing same
GB1074492A (en) Novel processes for preparing steroid compounds, the comopounds when thus prepared, novel steroid compounds thereby prepared, and pharmaceutical compositions containing the novel compounds
IE36592L (en) Pregnane derivatives.
GB1504132A (en) 6beta-fluorosteroids of the pregnane series
GB1272688A (en) Sulphamido-steroids and the preparation thereof
GB1145393A (en) Improvements in or relating to 17-‡-(alka-1',3'-diynyl)-steroids
GB1464509A (en) Esters of steroid 21-ols
IE35822L (en) 6ó, 16ó-dimethylsteroids.
GB1193366A (en) Gona-4,9,11-Trienes, Process for their Preparation, and Compositions Incorporating them
GB1438612A (en) Glycyrrhetinic acid derivatives
GB1317185A (en) Acyloxy-3alpha-hydroxy-pregnones
GB1285263A (en) IMPROVEMENTS IN OR RELATING TO 6alpha,6beta-DIFLUORO STEROIDS
GB1137596A (en) Therapeutically active acylamino-phenol-alkanols
GB1180176A (en) Novel Steroid 21-Esters, their Preparation, and Compositions containing them
GB1527249A (en) 6-fluoro-16-methyl-pregna-1,4,8-triene-3,20-diones
GB1303008A (enExample)
GB1214507A (en) 03-alkyl-11-oxygenated-gonenes
GB1101117A (en) Steroidal 2ª‡-carbonylhydrazones
GB1215164A (en) 21-sulphonated pregnadienes
GB976277A (en) New oestradiol esters and process for their production

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee